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A coupled chromogenic reaction (based on an agar overlay combining NADH, pyruvate kinase, lactate
dehydrogenase, phosphoenolpyruvate, ATP, and kanamycin sulfate with thiazolyl blue-phenazine methosulfate
for detection of NADH consumption) was optimized for the detection of aminoglycoside phosphotransferases
(APHs). When used after analytical isoelectrofocusing of bacterial extracts from APH-producing strains, this
method revealed one band in each of two strains with a genetically confirmed APH (3*) I and two bands in
another strain with both APH (3*) I and APH (3*) VI, whereas no bands were detected in susceptible control
strains or in aminoglycoside-resistant microorganisms without APH genes.
The most common mechanism of acquired resistance to
aminoglycosides in clinical isolates is that of aminoglycoside-
modifying enzymes (3). These enzymes are capable of three
general reactions: N acetylation, O nucleotidylation, and O
phosphorylation (1). The modifying enzymes present in resis-
tant bacteria may be studied by examining the resistance phe-
notype with substrate or nonsubstrate antibiotics, which merely
provides an indication of enzyme types (5). However, as sev-
eral different enzyme types (6) and isozymes may occur in an
individual isolate, attempts to recognize each component may
be difficult, since several resistance phenotypes may be super-
imposed.
Resistance phenotypes and hybridization with DNA probes
specific for known enzymes provide a reliable assessment of
resistance in an isolate (2). However, as the complete set of
probes is available to only a few laboratories around the world,
most laboratories are unable to test for them. Moreover, any
putative new enzyme would be detected only after failing to
hybridize to all known probes while carrying a new resistance
pattern or a resistance pattern resembling that corresponding
to a known gene.
In this study, an attempt was made to develop a coupled
chromogenic system to detect aminoglycoside phosphotrans-
ferase (APH) activity in cell extracts after separation of the
enzymes by analytical isoelectrofocusing, which is currently
used for b-lactamase characterization.
MATERIALS AND METHODS
Resistant bacteria with phenotypically and genetically characterized enzymes
were kindly provided by A. Rossi from the Institute C. G. Malbra´n, Buenos
Aires, Argentina. The strains and the genes encoding the modifying enzymes are
as follows: Proteus mirabilis INM 8628, aph (39)I 1 ant (29); P. mirabilis INM 900,
aph (39)I 1 aph (39)VI 1 ant (29); Escherichia coli INM 7251, aph (39)I 1 aac
(69); E. coli ATCC 11105, none; and P. mirabilis CCMA-29 1157, none (INM,
Instituto Nacional de Microbiologı´a Carlos Malbra´n; ATCC, American Type
Culture Collection; CCMA-29, Coleccio´n de Cultivos Microbianos, [Facultad de
Farmacia y Bioquı´mica, Universidad de Buenos Aires]).
Bacterial cells were grown to the late logarithmic phase in 500 ml of brain
heart infusion (Merck Quimica Argentina) at 37°C in the presence of 50 mg of
kanamycin (Armstrong) per ml, harvested by centrifugation (6,000 3 g, 30 min,
4°C), resuspended in 10 mM Tris HCl–10 mM magnesium acetate–25 mM
ammonium chloride, pH 7.8 (all chemicals were purchased from Merck Quimica
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Argentina), collected by centrifugation, and resuspended in the same buffer. The
suspension was ice cooled and disrupted with six 30-s bursts in a Vibracell VC
500 sonicator. Cell extracts were then clarified by centrifugation (15,000 3 g, 30
min, at 4°C), and the supernatants were concentrated to 1 ml by ultrafiltration
through an Amicon 10 membrane.
Enzymatic activity was confirmed by incubating extracts with a small amount of
kanamycin and ATP and monitoring the loss of drug activity by a standard disk
method (2).
Biochemical detection of phosphotransferase activity in the concentrated su-
pernatants was carried out by a coupled colorimetric reaction as follows. The
melted reaction medium thermostated to 42°C contained 0.9% agar, 10 mM Tris
HCl, 10 mM magnesium acetate, and 25 mM ammonium chloride, pH 7.8. The
following freshly prepared solutions were added to obtain the indicated final
concentrations: NADH, 16 mM; pyruvate kinase, 76 IU; lactate dehydrogenase,
640 IU; phosphoenolpyruvate (32 mM; ATP, 8 mM (all purchased from Sigma
Chemical Company), as well as kanamycin sulfate, gentamicin, or neomycin (0.5
to 2.3 mM) (kindly supplied by Armstrong) by adding concentrated solutions (4).
For qualitative detection, the mixture was poured onto glass plates. Once it had
solidified, a disk containing 10 ml of the concentrated supernatant or the same
amount of an extract lacking phosphotransferase genes (negative control) was
poured on and incubated for an hour in darkness at 37°C. A 10 mM thiazolyl blue
(MTT) (Sigma)–1 mM phenazine methosulfate (PMS) (Sigma) water solution
(7) was added and allowed to react at room temperature, until a blue color
became evident (between 1 and 5 min). The enzymatic cascade is presented in
Fig. 1. Analytical isoelectrofocusing of the concentrated supernatant was carried
out with Pharmacia precast gel Inmobiline dry plates, pH 4.0 to 7.0 (Pharmacia
Biotech, Uppsala, Sweden) according to the manufacturer’s instructions. Local-
ization of phosphotransferase activity was carried out by pouring the reaction
mixture onto the gels, as described above.
RESULTS AND DISCUSSION
Figure 2 shows preliminary biochemical detection of phos-
photransferase activity in crude extracts, using neomycin 1 mM
as substrate. The same results were obtained when gentamicin
was used at the same or higher concentration (data not shown).
As shown in Fig. 3, at an apparent pI of roughly 4.1, one
active band appeared in two strains known to express a single
phosphotransferase. A second band was observed at pI 4.4 in a
strain harboring two such enzymes (Fig. 4). The band at 4.4 is
in good agreement with the predicted pI value (8).
As expected from a reaction with an overall consumption of
aminoglycoside, phosphoenolpyruvate, and MTT-PMS (re-
duced form) and production of aminoglycoside phosphate, lac-
tate, and MTT-PMS (oxidized form), in the presence of the
specific enzymatic system, only extracts with APHs were posi-
tive by this method. Although the enzymatic cascade theoret-
ically might be less specific due to the action of other NADH
or ATP-consuming or -producing systems, the absence of a
suitable substrate in the reaction mixture precluded these re-
actions. Moreover, control extracts from strains lacking APH
activity produced no decolorization. Furthermore, the wide-
spread aminoglycoside acetyltransferase-producing strains in
Argentina, most of which lack APH genes, also did not show
any nonspecific reaction (data not shown).
Although only three APH-producing strains have been an-
alyzed so far, the lack of nonspecific reactions and the detec-
tion of two active bands in the strain with two different APH
genes suggest that this will be a useful method especially for
the analysis of clinical isolates where phenotypic resistance
cannot be attributed to any particular enzyme or isozyme.
Hopefully, it may provide an easy and fast method for semi-
quantitative studies of APH activity in strains encoding the
same (or different) information at the DNA level or presenting
dissimilar expression. Lastly, our approach may also be used to
FIG. 2. Ten microliters of an extract of E. coli INM 7251 was poured onto
disk A. The same amount of a nonresistant strain (E. coli ATCC 11105) was
poured onto disk B. Phosphotransferase activity was detected as described in the
text.
FIG. 3. Twenty microliters from each bacterial extract was electrofocused on
Inmobiline dry plates (pH 4.0 to 7.0) at 2,000 V for 3.5 h. Phosphotransferase
activity was detected as described in the text. Strains are indicated on the left.
FIG. 4. Twenty microliters from each bacterial extract was electrofocused on
Inmobiline dry plates (pH 4.0 to 7.0) at 2,000 V for 3.5 h. Phosphotransferase
activity was detected as described in the text. Strains are indicated on the left.
VOL. 42, 1998 CHROMOGENIC DETECTION OF APHs 229
 o
n








detect presumptively novel enzymes, when specific probes are
not yet available.
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